• • Company Profile

Company Profile

MDL provides fast, accurate, cutting-edge genetic diagnostic tests for patient management and research purposes with a focus on, osteonecrosis, polycystic ovary disease, thrombophilia, hypofibrinolysis (thromboses or blood clotting disorders), cardiac risk factors, and pharmacogenetics. Some of the benefits of using MDL's
service include:

• Cutting edge tests like PAI-1 (plasminogen activator inhibitor)
• New genetic test development
• Low volume tests
• Esoteric such as DPD (Dihydropyrimidine Dehydrogenase), eNOS (endothelial nitric oxide synthase), and stromelysin
• Knowledgeable and available support staff
• Definitive test results

Buerger Disease (thromboangiitis obliterans). This disease occurs in smokers and it has a prevalence of about 13 per 100,000 smokers. Buerger Disease study at the Cholesterol Center at Jewish Hospital in Cincinnati, Ohio